February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

hypertension. Researchers have long suspected a link between the use of selective serotonin reuptake inhibitors, or SSRIs, and the condition, but previous studiess have been small and inconclusive (with results ranging from theree being no link to a six times greaterr risk). Article link: http://parenting.blogs.nytimes.com/2012/01/13/antidepressant-use-linked- toincreased-pulmonary-hypertension-risk-in-infants/ CDC Warns Against Sharing Insulin Pens January 13, 2012 Source website: http: ://www.nytimes.com/ Due to a growing number of reports about improper use of insulin pens, the U.S. . Centers for Disease Control and Prevention has issued a reminder that the devices must never be used on more than one person. Using insulin pens on more than one person puts people at risk for infectionn with blood-bornwarns. Infection can occur even if an insulin pen' 's needle is changed. pathogens such as hepatitis viruses and HIV, which causes AIDS, the agency Article link: http://news.yahoo.com/cdc-warns-against-sharing-insulin-pens-190308004.html Source website: http: ://news.yahoo.com/ Drug Shortages Raise Risk of Cancer Counterfeits, U.S. Says January 13, 2012 Shortages of some injectable cancer drugs have created an opening for dangerous unapproved versions of Roche’s Herceptin and Amgen’s Neupogen to be sold to clinics and other health-care providers, the U.S. said. The Food and Drug Administration issued a notice today warning providers to avoid direct solicitations from unproven sources and only buy drugs through approved channels. Article link: http://www.bloomberg.com/news/2012-01-13/drug-shortages-raise-the-risk- risk. Some pediatricians continue to do electrocardiograms (EKGs) on children before starting them on medication for attention-deficit hyperactivity disorder, new research suggests, even though many experts say the ofcounterfeit-cancer-medicines-u-s-says.html website: http: ://www.bloomberg.com/ Pediatricians Split on Heart Tests Before Kids January 16, 2012 Source About 15 percent order EKGs; recent studiess say drugs don't pose heart latest evidence shows it isn't really necessary. Article link: http://consumer.healthday.com/Article.asp?AID=660668 Source website: http: ://consumer. healthday.com/ Glaxo, Roche Breast-Cancer Treatments Work Better Combined, Study Shows January 16, 2012 Combining GlaxoSmithKline’s Tykerb drug with Roche’s Herceptin to treat breast cancer was almost twice as effective as single-drug therapy, according to researchers in a 23-country clinical trial. Article link: http://www.bloomberg.com/news/2012-01-17/glaxo-roche-breast-cancer- treatmentswork-better-combined-study-shows.html Source website: http: ://www.bloomberg.com/ Study Disputes Finding That Hormone Therapy Causes Breast Cancer January 16, 2012 16
The Million Women Study, a U.K. project that found hormone replacement therapy led to increased risk of breast cancer, had flaws that call into question the findings, according to a review of the evidence led by a South African researcher. Article link: http://www.bloomberg.com/news/2012-01-16/study-disputes-finding-that- take hormonetherapy-causes-breast-cancer.html Source website: http: ://www.bloomberg.com/ New 'smart' pill tells patients when drugs dose due January 17, 2012 A new "intelligent" pill that tells patients how to better follow doctors’ orders and medication properly is to go on sale in Britain within months, it has been announced. Article link: http://www.telegraph.co.uk/health/healthnews/9019651/New-smart-pill-tells- study patientswhen-drugs-dose-due.html Source website: http: ://www.telegraph.co.uk/ Antidepressants Might Raise Fall Risk in Nursing Homes January 18, 2012 Residents with dementia taking so-called SSRIs seem to be at higherr risk of injury, suggests Antidepressants called selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of falls in nursing home residents with dementia, a new study finds. Article link: http://consumer.healthday.com/Article.asp?AID=660819 Source website: http: ://consumer. healthday.com/ Bristol, AstraZenec ca Diabetes Drug Fails to Win FDA Backing January 19, 2012 Bristol-Myers Squibbb Co. and AstraZeneca Plc failed to win U.S. clearance to sell the first in a new class of experimental diabetes pills as regulators sought more data on the medicine’s safety. The Food and Drug Administrati ion is seeking data from ongoing studies of the treatment, dapagliflozin, in adults with Type 2 diabetes and may require new clinical trials to better assess the risks and benefits, the companies said today in a statement. Bristol-Myers, based in New York, and London-based AstraZeneca remain committedd to the drug, they said. Article link: http://www.businessweek.com/news/2012-01-19/bristol-astrazeneca-diabetes- drugfails-to-win-fda-backing.html website: http: ://www.businessweek.com/ Source Recalls PRODUCT (CLASSS I) Virility Max, 10 Capsules, Supplement Facts Serving Size 1 Capsule, Keep away from children, For mens use only, Contains 450 mg, Rowdy Lamb, Puncture vine, Ginnsue Herb, Aarons Rod, Matrimony Vine, Cocky Cinnamon. Recall # D-1184-2012 CODE Lot #: 10090571 RECALLING FIRM/MANUFACTURERR Recalling Firm: Keime, Inc., Boca Raton, FL, by press release on November 11, 2011. Manufacturer: ABCO Laboratories, Inc., Fairfield, CA. Firm initiated recall is ongoing. REASON Marketed Without an Approved NDA/ANDA A: Product found to contain sulfoaildenafil and sulfosildenafil, analogues of sildenafil, the active ingredient in a FDA approved drug used to treat erectile dysfunction, making Virility Max an unapproved new drug. 17
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15: Statins raise risk of Type 2 diabet
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33 and 34: Lidocaine 2% (with epinephrine 1:10
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?